ClinicalTrials.gov
ClinicalTrials.gov Menu

Comparison of Immune Response Following Surgical Management of Renal Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00289146
Recruitment Status : Terminated
First Posted : February 9, 2006
Last Update Posted : September 24, 2013
Sponsor:
Information provided by (Responsible Party):
Kenneth Ogan, MD, Emory University

Brief Summary:
Examine the effects of renal surgery on the immune system.

Condition or disease
Kidney Cancer

Detailed Description:
Prospective study examining the effects of different surgical procedures on immune function. This may have bearing on overall cancer specific recurrence and survival.

Study Type : Observational
Estimated Enrollment : 50 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Comparison of Immune Response Following Surgical Management of Renal Tumors
Study Start Date : November 2005
Actual Primary Completion Date : August 2006
Actual Study Completion Date : August 2006

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Kidney Cancer




Biospecimen Retention:   Samples Without DNA
Blood samples


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Patients undergoing open or laparoscopic surgeries for the treatment of kidney tumors.
Criteria

Inclusion Criteria:

  • Kidney tumor patients scheduled for open or laparoscopic surgery

Exclusion Criteria:


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00289146


Locations
United States, Georgia
Emory University
Atlanta, Georgia, United States, 30322
Sponsors and Collaborators
Emory University
Investigators
Principal Investigator: Kenneth Ogan, MD Emory University

Responsible Party: Kenneth Ogan, MD, Associate Professor, Emory University
ClinicalTrials.gov Identifier: NCT00289146     History of Changes
Other Study ID Numbers: 0021-2005
First Posted: February 9, 2006    Key Record Dates
Last Update Posted: September 24, 2013
Last Verified: September 2013

Keywords provided by Kenneth Ogan, MD, Emory University:
kidney cancer, immunology

Additional relevant MeSH terms:
Kidney Neoplasms
Carcinoma, Renal Cell
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Kidney Diseases
Urologic Diseases
Adenocarcinoma
Carcinoma
Neoplasms, Glandular and Epithelial
Neoplasms by Histologic Type